Method for treating hepatitis C virus infection in treatment failure patients

Details for Australian Patent Application No. 2002327009 (hide)

International Classifications

Event Publications

23 January 2003 Complete Application Filed

Priority application(s): 60/326,100 28.09.01 US

26 June 2003 Application Open to Public Inspection

Published as AU-B-2002327009

19 April 2007 Assignment before Grant

Intermune, Inc The application has been assigned to Valeant Pharmaceuticals North America

19 April 2007 Application Accepted

Published as AU-B-2002327009

17 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.